Search
HCW Biologics Inc
HCWBAdd to Watchlist
2.698USD
+0.198+7.90%
Close 07-24 16:00（ET）Quotes delayed by 15 min
8.85MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of HCW Biologics Inc is 8.00, ranking 168 out of 386 in the Biotechnology & Medical Research industry. The average price target is 35.00, with a high of 35.00 and a low of 35.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
30.000
Target Price
+941.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
HCW Biologics Inc
HCWB
1
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is HCW Biologics Inc's price target?
Analysts forecast that HCW Biologics Inc's price target is USD 35.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 35.00.
How have HCW Biologics IncHCWB's recent earnings per share performed?
The market expectation was USD 2.19, while HCW Biologics IncHCWB's earnings per share (EPS) for the previous quarter was USD -10.63. EPS for the next quarter is expected at USD -1.98.
What is the analyst rating for HCW Biologics Inc?
Based on the ratings of HCW Biologics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.